AstraZeneca Announces Increased Coverage of BRILINTA Through Plan Preferred Formulary Status on Medco Health Solutions

by Eddie Staley, Benzinga Editor

March 22, 2012 10:00 AM | 12 seconds read | Make a Comment

AstraZeneca

AZN

today announced that BRILINTA (ticagrelor) tablets received Plan Preferred Tier 2 formulary access on Medco Health Solutions' National commercial formulary and Preferred Brand formulary status on its Medicare Part D drug list.

Market News and Data brought to you by Benzinga APIs

Posted In: News FDA

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

AstraZeneca Announces Increased Coverage of BRILINTA Through Plan Preferred Formulary Status on Medco Health Solutions